European Patent Bulletin 2012/09 - European Patent Office
European Patent Bulletin 2012/09 - European Patent Office European Patent Bulletin 2012/09 - European Patent Office
(C07D) I.1(2) (74) HOFFMANN EITLE, Patent- und Rechtsanwälte Arabellastraße 4, 81925 München, DE C07D 471/04 → (51) A61K 31/192 C07D 471/04 → (51) C07D 209/14 C07D 471/04 → (51) C07D 213/16 (51) C07D 471/08 (11) 2 423 212 A1 C07B 61/00 (25) Ja (26) En (21) 10767170.3 (22) 23.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) JP 2010/057278 23.04.2010 (87) WO 2010/123115 2010/43 28.10.2010 (30) 24.04.2009 JP 2009105926 (54) VERFAHREN ZUR HERSTELLUNG EINER 2-AZAADAMANTANVERBINDUNG AUS EI- NER BICYCLOCARBAMATVERBINDUNG PROCESS FOR PRODUCTION OF 2-AZAA- DAMANTANE COMPOUND FROM BICY- CLOCARBAMATE COMPOUND PROCÉDÉ DE FABRICATION D'UN COMPOSÉ 2-AZAADAMANTANE À PARTIR D'UN COMPOSÉ BICYCLOCAR- BAMATE (71) Nissan Chemical Industries, Ltd., 7-1 Kanda- Nishiki-cho 3-chome, Chiyoda-ku Tokyo 101-0054, JP (72) KOZAWA, Masami, Funabashi-shi Chiba 274-8507, JP ENDO, Yuki, Funabashi-shi Chiba 274-8507, JP (74) Blodig, Wolfgang, Wächtershäuser & Hartz Patentanwälte Weinstraße 8, D-80333 München, DE C07D 471/18 → (51) C07D 401/04 C07D 487/04 → (51) C07C 69/65 C07D 487/04 → (51) C07D 209/14 C07D 491/04 → (51) C07D 217/22 C07D 493/04 → (51) A61K 31/335 C07D 493/04 → (51) C07D 401/04 (51) C07D 495/04 (11) 2 423 213 A1 C07D 335/06 C07D 335/04 A61K 31/4365 A61K 31/382 A61K 9/06 A61K 9/08 A61K 9/02 A61K 9/107 A61K 9/20 A61K 9/48 A61K 9/00 A61P 31/04 A61P 31/10 A61P 35/00 (25) Zh (26) En (21) 10766578.8 (22) 09.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) CN 2010/000471 09.04.2010 (87) WO 2010/121487 2010/43 28.10.2010 (30) 23.04.2009 CN 200910137455 06.06.2009 CN 200910203152 (54) ZUBEREITUNG UND VERWENDUNG NEUER ANTIBIOTISCHER UND ANTITU- MORVERBINDUNGEN SOWIE DERIVATEN DARAUS PREPARATION AND USE OF NOVEL ANTIBIOTIC, ANTICANCER COMPOUNDS AND DERIVATIVES THEREOF PRÉPARATION ET UTILISATION DE NOUVEAUX COMPOSÉS ANTIBIOTIQUES Europäisches Patentblatt European Patent Bulletin Bulletin européen des brevets ET ANTICANCÉREUX ET DE LEURS DÉRIVÉS (71) Yang, Gengliang, College of Pharmaceutical Sciences Hebei University No.180 Wusidonglu, Baoding Hebei 071002, CN (72) MA, Zhengyue, Hebei 071002, CN TIAN, Wei, Hebei 071002, CN FANG, Baoling, Hebei 071002, CN WANG, Ge, Hebei 071002, CN LI, Linbo, Hebei 071002, CN YANG, Chunliu, Hebei 071002, CN BAI, Ligai, Hebei 071002, CN (74) Plucker, Guy, et al, OFFICE KIRKPATRICK Avenue Wolfers, 32, B-1310 La Hulpe, BE C07D 495/04 → (51) C07D 209/14 C07D 495/04 → (51) C08G 61/12 C07D 498/04 → (51) C07D 401/04 C07F 1/08 → (51) C07D 213/16 C07F 1/10 → (51) C07D 213/16 C07F 7/10 → (51) C07C 211/61 C07F 7/10 → (51) C07D 307/91 C07F 7/18 → (51) C07D 209/70 C07F 9/572 → (51) A61K 31/662 C07F 9/6558 → (51) A61K 31/662 (51) C07F 15/00 (11) 2 423 214 A1 H01L 51/00 (25) En (26) En (21) 10172814.5 (22) 13.08.2010 (84) AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR BA ME RS (54) Lichtemittierende Materialien für Elektronik Light emitting materials for Electronics Matériaux électroluminescents pour appareils électroniques (71) Solvay SA, Rue du Prince Albert, 33, 1050 Brussels, BE (72) BARANOFF, Etienne David, RENENS VD, 1020, CH NAZEERUDDIN, Mohammad Khaja, 1024, ECUBLENS, CH GRAETZEL, Michael, 1025, SAINT SULPICE, CH (74) Langfinger, Klaus Dieter, et al, Boehmert & Boehmert Pettenkoferstrasse 20-22, 80336 München, DE C07F 15/02 → (51) C07D 213/53 C07F 15/02 → (51) C07D 231/38 (51) C07H 19/073 (11) 2 423 215 A1 A61K 31/7068 A61P 35/00 (25) Zh (26) En (21) 10766577.0 (22) 25.03.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) CN 2010/000372 25.03.2010 (87) WO 2010/121486 2010/43 28.10.2010 (30) 21.04.2009 CN 200910020716 (54) AUF GEMCITABINSTRUKTUR BASIE- RENDE PRODRUGS SOWIE SYNTHETI- SCHES VERFAHREN UND ANWENDUNG 256 Anmeldungen Applications Demandes (09/2012) 29.02.2012 PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF PROMEDICAMENTS BASES SUR UNE STRUCTURE DE GEMCITABINE, PROCEDE DE SYNTHESE ET APPLICA- TION ASSOCIES (71) Sanlugen Pharmatech Ltd., 5/F, Zonghe Building No. 18877 Jingshi Road, Jinan, Shandong 250100, CN (72) XUE, Xiaoxia, Shandong 272000, CN LI, Gang, Shandong 250100, CN SUN, Changjun, Shandong 250100, CN LI, Wenbao, Shandong 250100, CN (74) Cornish, Kristina Victoria Joy, Kilburn & Strode LLP 20 Red Lion Street, London WC1R 4PJ, GB C07H 21/00 → (51) C12Q 1/68 (51) C07H 21/02 (11) 2 423 216 A1 C07H 21/04 C12P 19/34 C12P 21/00 C12N 15/09 C12N 15/82 C12N 15/00 C12Q 1/70 C12Q 1/68 (25) En (26) En (21) 11005809.6 (22) 01.12.2004 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR (30) 01.12.2003 US 525989 P (54) Replikationsfähiges Hepatitis-C-Virus und Verwendungsverfahren Replication competent hepatitis C virus and methods of use Virus de l'hépatite C compétent pour la réplication et procédés d'utilisation (71) Board Of Regents, The University Of Texas System, 201 West 7th Street, Austin, TX 78701, US (72) Lemon, Stanley M., Chapel Hill, NC 27517, US Yi, MinKyung, Galveston, Texas 77551, US (74) Miles, John Stephen, et al, Potter Clarkson LLP Park View House 58 The Ropewalk, Nottingham NG1 5DD, GB (62) 04812596.7 / 1 694 694 C07H 21/02 → (51) C12Q 1/68 C07H 21/04 → (51) C07H 21/02 C07H 21/04 → (51) C12Q 1/68 C07K 1/14 → (51) C07K 7/00 (51) C07K 1/22 (11) 2 423 217 A1 C07K 14/32 C12N 15/62 (25) En (26) En (21) 10075359.9 (22) 23.08.2010 (84) AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR BA ME RS (54) Peptide und Proteinaffinitäts-Tag aus Mistic-Protein Peptide and protein affinity tag from mistic protein Etiquette d'affinité de peptide et de protéine dérivant de la protéine mistic (71) Forschungsverbund Berlin E.V., Rudower Chaussee 17, 12489 Berlin, DE (72) Bordag, Natalie, 13437 Berlin, DE Keller, Sandro, 67655 Kaiserslautern, DE (74) Boeckh, Tobias, HERTIN Anwaltssozietät Kurfürstendamm 54/55, 10707 Berlin, DE C07K 1/22 → (51) B01D 15/38
(C07K) I.1(2) C07K 1/22 → (51) C07K 7/00 (51) C07K 7/00 (11) 2 423 218 A1 C07K 1/14 C07K 16/44 C07K 19/00 C12N 5/10 C12N 15/09 C07K 1/22 C12P 21/08 (25) Ja (26) En (21) 10767070.5 (22) 21.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) JP 2010/057028 21.04.2010 (87) WO 2010/123013 2010/43 28.10.2010 (30) 22.04.2009 JP 2009103925 (54) MARKIERUNGSPEPTID MIT PROTEASE- ERKENNUNGSSEQUENZ UND VERWEN- DUNG TAG PEPTIDE HAVING PROTEASE RECOGNITION SEQUENCE AND UTILI- ZATION OF SAME PEPTIDE MARQUEUR AYANT UNE SÉQUENCE DE RECONNAISSANCE DE PROTÉASE ET SON UTILISATION (71) Osaka University, 1-1, Yamadaoka, Suita-shi Osaka 565-0871, JP (72) TAKAGI, Junichi, Suita-shi Osaka 565-0871, JP (74) Witte, Weller & Partner, Königstrasse 5, 70173 Stuttgart, DE C07K 14/00 → (51) G01N 33/50 C07K 14/025 → (51) C12Q 1/68 C07K 14/32 → (51) C07K 1/22 C07K 14/415 → (51) A01H 1/00 C07K 14/415 → (51) B01D 15/38 C07K 14/435 → (51) A61K 38/26 (51) C07K 14/47 (11) 2 423 219 A1 C07K 14/75 C07K 14/76 C07K 14/78 C07K 14/79 A61K 38/04 (25) En (26) En (21) 11177609.2 (22) 29.01.2008 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (30) 30.01.2007 US 898347 P (54) Regulatorische T-Zellen-Epitopen sowie Zusammensetzungen damit und Anwendungen davon Regulatory t cell epitopes, compositions and uses thereof Épitopes de lymphocytes t régulateurs, compositions et utilisations de ceux-ci (71) Epivax, Inc., 146 Clifford Street, Providence, RI 02903, US (72) De Groot, Anne, Providence, RI Rhode Island 02906, US Martin, William, Cumberland, RI Rhode Island 02864, US Rivera, Dan, Providence, RI Rhode Island 02903, US (74) Murphy, Colm Damien, Ipulse 26 Mallinson Road, London SW11 1BP, GB (62) 08713321.1 / 2 125 883 (51) C07K 14/47 (11) 2 423 220 A1 C07K 14/75 C07K 14/76 C07K 14/78 C07K 14/79 A61K 38/04 (25) En (26) En (21) 11177625.8 (22) 29.01.2008 Europäisches Patentblatt European Patent Bulletin Bulletin européen des brevets (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (30) 30.01.2007 US 898347 P (54) Regulatorische T-Zellen-Epitopen sowie Zusammensetzungen damit und Anwendungen davon Regulatory T cell epitopes, compositions and uses thereof Épitopes de lymphocytes t régulateurs, compositions et utilisations de ceux-ci (71) Epivax, Inc., 146 Clifford Street, Providence, RI 02903, US (72) De Groot, Anne, Providence, RI Rhode Island 02906, US Martin, William, Cumberland, RI Rhode Island 02864, US Rivera, Dan, Providence, RI Rhode Island 02907, US (74) Murphy, Colm Damien, Ipulse 26 Mallinson Road, London SW11 1BP, GB (62) 08713321.1 / 2 125 883 (51) C07K 14/47 (11) 2 423 221 A1 C07K 14/75 C07K 14/76 C07K 14/78 C07K 14/79 A61K 38/04 (25) En (26) En (21) 11177630.8 (22) 29.01.2008 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (30) 30.01.2007 US 898347 P (54) Regulatorische T-Zellen-Epitopen sowie Zusammensetzungen damit und Anwendungen davon Regulatory t cell epitopes, compositions and uses thereof Épitopes de lymphocytes t régulateurs, compositions et utilisations de ceux-ci (71) Epivax, Inc., 146 Clifford Street, Providence, RI 02903, US (72) De Groot, Anne, Providence, RI Rhode Island 02906, US Martin, William, Cumberland, RI Rhode Island 02864, US Rivera, Dan, Providence, RI Rhode Island 02903, US (74) Murphy, Colm Damien, Ipulse 26 Mallinson Road, London SW11 1BP, GB (62) 08713321.1 / 2 125 883 (51) C07K 14/47 (11) 2 423 222 A1 C07K 14/75 C07K 14/76 C07K 14/78 C07K 14/79 A61K 38/04 (25) En (26) En (21) 11177634.0 (22) 29.01.2008 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR (30) 30.01.2007 US 898347 P (54) Regulatorische T-Zellen-Epitopen sowie Zusammensetzungen damit und Anwendungen davon Regulatory t cell epitopes, compositions and uses thereof Épitopes de lymphocytes t régulateurs, compositions et utilisations de ceux-ci (71) Epivax, Inc., 146 Clifford Street, Providence, RI 02903, US (72) De Groot, Anne, Providence, RI Rhode Island 02906, US Martin, William, Cumberland, RI Rhode Island 02864, US Rivera, Dan, Providence, RI Rhode Island 02903, US (74) Murphy, Colm Damien, Ipulse 26 Mallinson Road, London SW11 1BP, GB 257 Anmeldungen Applications Demandes (09/2012) 29.02.2012 (62) 08713321.1 / 2 125 883 C07K 14/475 → (51) C07K 19/00 (51) C07K 14/575 (11) 2 423 223 A1 C07K 17/08 A61K 38/22 A61K 47/48 A61P 3/10 A61P 3/04 (25) Zh (26) En (21) 10766649.7 (22) 23.04.2010 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (86) CN 2010/072094 23.04.2010 (87) WO 2010/121559 2010/43 28.10.2010 (30) 23.04.2009 CN 200910135363 (54) NEUE EXENDINVARIANTE UND KON- JUGAT DARAUS NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF NOUVEAU VARIANT D'EXENDINE ET SON CONJUGUÉ (71) Pegbio Co., Ltd., Suite 417 Building A3 Biobay 218 Xinghu Street Industrial Park, Suzhou, Jiangsu 215123, CN (72) XU, Michael M., Suzhou Jiangsu 215123, CN WANG, Yongxiang, Shanghai 200240, CN ZHANG, Yinghui, Suzhou Jiangsu 215123, CN LUO, Xiaosu, Suzhou Jiangsu 215123, CN GONG, Nian, Shanghai 200240, CN ZHANG, Lijie, Suzhou Jiangsu 215123, CN ZHOU, Xiangjun, Suzhou Jiangsu 215123, CN (74) Gerbino, Angelo, et al, Jacobacci & Partners S.p.A. Corso Emilia 8, 10152 Torino, IT C07K 14/575 → (51) A61K 38/00 C07K 14/705 → (51) C07C 43/225 C07K 14/705 → (51) G01N 33/53 (51) C07K 14/745 (11) 2 423 224 A1 C12N 9/64 A61K 38/36 C12N 15/57 A61P 7/04 (25) En (26) En (21) 11182949.5 (22) 15.11.2006 (84) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR AL BA HR MK RS (30) 15.11.2005 US 736680 P (54) Zusammensetzungen und Verfahren zur Hämostasenmodulierung Compositions and methods for modulating hemostasis Compositions et procédés de modulation de l'hémostase (71) The Children's Hospital of Philadelphia, 34th Street & Civic Center Boulevard, Philadelphia, PA 19104, US (72) Camire, Rodney M., Sicklerville, NJ 08081, US (74) Cripps, Joanna Elizabeth, et al, Mewburn Ellis LLP 33 Gutter Lane, London EC2V 8AS, GB (62) 06846312.4 / 1 948 690 C07K 14/75 → (51) C07K 14/47 C07K 14/76 → (51) C07K 14/47 C07K 14/78 → (51) C07K 14/47 C07K 14/79 → (51) C07K 14/47 C07K 14/81 → (51) C07K 19/00
- Page 205 and 206: (A61K) I.1(2) (54) Elektrochemisch
- Page 207 and 208: (A61K) I.1(2) D'Souza, Lawrence J.,
- Page 209 and 210: (A61L) I.1(2) (54) BIOLOGISCH ABBAU
- Page 211 and 212: (A61M) I.1(2) (72) KOSEKI, Hiroaki,
- Page 213 and 214: (A61P) I.1(2) pherol, de myricetine
- Page 215 and 216: (B01D) I.1(2) (51) B01D 39/14 (11)
- Page 217 and 218: (B02C) I.1(2) (54) Scheibenwalzenm
- Page 219 and 220: (B21K) I.1(2) B21K 1/14 → (51) F1
- Page 221 and 222: (B23K) I.1(2) (25) Ru (26) De (21)
- Page 223 and 224: (B25B) I.1(2) (21) 11405306.9 (22)
- Page 225 and 226: (B27N) I.1(2) (74) Jiminez Brinquis
- Page 227 and 228: (B29D) I.1(2) (25) En (26) En (21)
- Page 229 and 230: (B41J) I.1(2) (74) Weser, Wolfgang,
- Page 231 and 232: (B60C) I.1(2) (84) AL AT BE BG CH C
- Page 233 and 234: (B60H) I.1(2) (72) Yokoyama, Atsush
- Page 235 and 236: (B60N) I.1(2) (51) B60N 2/42 (11) 2
- Page 237 and 238: (B60R) I.1(2) (25) Ja (26) En (21)
- Page 239 and 240: (B62B) I.1(2) (74) Leckey, David He
- Page 241 and 242: (B62M) I.1(2) (51) B62M 3/08 (11) 2
- Page 243 and 244: (B65B) I.1(2) (30) 25.08.2010 DE 10
- Page 245 and 246: (B65D) I.1(2) (51) B65D 85/68 (11)
- Page 247 and 248: (B66C) I.1(2) B66C 17/00 → (51) B
- Page 249 and 250: (C01G) I.1(2) (30) 23.08.2007 US 95
- Page 251 and 252: (C07C) I.1(2) (51) C07C 211/63 (11)
- Page 253 and 254: (C07D) I.1(2) HIGASHIMURA, Hideyuki
- Page 255: (C07D) I.1(2) (51) C07D 401/04 (11)
- Page 259 and 260: (C07K) I.1(2) (74) Carpmaels & Rans
- Page 261 and 262: (C08G) I.1(2) (71) Cheil Industries
- Page 263 and 264: (C08L) I.1(2) (74) HOFFMANN EITLE,
- Page 265 and 266: (C09D) I.1(2) Encre à jet d'encre
- Page 267 and 268: (C09K) I.1(2) (72) Aoki, Shunji, An
- Page 269 and 270: (C12N) I.1(2) Cell isolation appara
- Page 271 and 272: (C12N) I.1(2) (51) C12N 15/64 (11)
- Page 273 and 274: (C12Q) I.1(2) (51) C12Q 1/68 (11) 2
- Page 275 and 276: (C22C) I.1(2) (72) KIM, Dong-Hyun,
- Page 277 and 278: (D02G) I.1(2) (71) RUD Ketten Riege
- Page 279 and 280: (D06F) I.1(2) Kim, Sung Min, Changw
- Page 281 and 282: (E03F) I.1(2) (71) VIEGA GmbH & Co.
- Page 283 and 284: (E05B) I.1(2) (74) Groot Koerkamp,
- Page 285 and 286: (F01D) I.1(2) (30) 31.08.2010 US 87
- Page 287 and 288: (F01D) I.1(2) (72) Kumm, Benjamin,
- Page 289 and 290: (F01K) I.1(2) Leone, Sal Albert, Sc
- Page 291 and 292: (F02B) I.1(2) (84) AT BE BG CH CY C
- Page 293 and 294: (F03D) I.1(2) (71) GENERAL ELECTRIC
- Page 295 and 296: (F16B) I.1(2) (21) 11177308.1 (22)
- Page 297 and 298: (F16H) I.1(2) Dispositif de serrage
- Page 299 and 300: (F16L) I.1(2) Mackenzie, Colin Jame
- Page 301 and 302: (F21V) I.1(2) (30) 24.08.2010 JP 20
- Page 303 and 304: (F23C) I.1(2) (25) De (26) De (21)
- Page 305 and 306: (F24D) I.1(2) Durcan, Michael, 3 Ho
(C07K) I.1(2)<br />
C07K 1/22 → (51) C07K 7/00<br />
(51) C07K 7/00 (11) 2 423 218 A1<br />
C07K 1/14 C07K 16/44<br />
C07K 19/00 C12N 5/10<br />
C12N 15/<strong>09</strong> C07K 1/22<br />
C12P 21/08<br />
(25) Ja (26) En<br />
(21) 10767070.5 (22) 21.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) JP 2010/057028 21.04.2010<br />
(87) WO 2010/123013 2010/43 28.10.2010<br />
(30) 22.04.20<strong>09</strong> JP 20<strong>09</strong>103925<br />
(54) MARKIERUNGSPEPTID MIT PROTEASE-<br />
ERKENNUNGSSEQUENZ UND VERWEN-<br />
DUNG<br />
TAG PEPTIDE HAVING PROTEASE<br />
RECOGNITION SEQUENCE AND UTILI-<br />
ZATION OF SAME<br />
PEPTIDE MARQUEUR AYANT UNE<br />
SÉQUENCE DE RECONNAISSANCE DE<br />
PROTÉASE ET SON UTILISATION<br />
(71) Osaka University, 1-1, Yamadaoka, Suita-shi<br />
Osaka 565-0871, JP<br />
(72) TAKAGI, Junichi, Suita-shi Osaka 565-0871,<br />
JP<br />
(74) Witte, Weller & Partner, Königstrasse 5,<br />
70173 Stuttgart, DE<br />
C07K 14/00 → (51) G01N 33/50<br />
C07K 14/025 → (51) C12Q 1/68<br />
C07K 14/32 → (51) C07K 1/22<br />
C07K 14/415 → (51) A01H 1/00<br />
C07K 14/415 → (51) B01D 15/38<br />
C07K 14/435 → (51) A61K 38/26<br />
(51) C07K 14/47 (11) 2 423 219 A1<br />
C07K 14/75 C07K 14/76<br />
C07K 14/78 C07K 14/79<br />
A61K 38/04<br />
(25) En (26) En<br />
(21) 111776<strong>09</strong>.2 (22) 29.01.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
(30) 30.01.2007 US 898347 P<br />
(54) Regulatorische T-Zellen-Epitopen sowie<br />
Zusammensetzungen damit und Anwendungen<br />
davon<br />
Regulatory t cell epitopes, compositions<br />
and uses thereof<br />
Épitopes de lymphocytes t régulateurs,<br />
compositions et utilisations de ceux-ci<br />
(71) Epivax, Inc., 146 Clifford Street, Providence,<br />
RI 02903, US<br />
(72) De Groot, Anne, Providence, RI Rhode Island<br />
02906, US<br />
Martin, William, Cumberland, RI Rhode<br />
Island 02864, US<br />
Rivera, Dan, Providence, RI Rhode Island<br />
02903, US<br />
(74) Murphy, Colm Damien, Ipulse 26 Mallinson<br />
Road, London SW11 1BP, GB<br />
(62) 08713321.1 / 2 125 883<br />
(51) C07K 14/47 (11) 2 423 220 A1<br />
C07K 14/75 C07K 14/76<br />
C07K 14/78 C07K 14/79<br />
A61K 38/04<br />
(25) En (26) En<br />
(21) 11177625.8 (22) 29.01.2008<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
(30) 30.01.2007 US 898347 P<br />
(54) Regulatorische T-Zellen-Epitopen sowie<br />
Zusammensetzungen damit und Anwendungen<br />
davon<br />
Regulatory T cell epitopes, compositions<br />
and uses thereof<br />
Épitopes de lymphocytes t régulateurs,<br />
compositions et utilisations de ceux-ci<br />
(71) Epivax, Inc., 146 Clifford Street, Providence,<br />
RI 02903, US<br />
(72) De Groot, Anne, Providence, RI Rhode Island<br />
02906, US<br />
Martin, William, Cumberland, RI Rhode<br />
Island 02864, US<br />
Rivera, Dan, Providence, RI Rhode Island<br />
02907, US<br />
(74) Murphy, Colm Damien, Ipulse 26 Mallinson<br />
Road, London SW11 1BP, GB<br />
(62) 08713321.1 / 2 125 883<br />
(51) C07K 14/47 (11) 2 423 221 A1<br />
C07K 14/75 C07K 14/76<br />
C07K 14/78 C07K 14/79<br />
A61K 38/04<br />
(25) En (26) En<br />
(21) 11177630.8 (22) 29.01.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
(30) 30.01.2007 US 898347 P<br />
(54) Regulatorische T-Zellen-Epitopen sowie<br />
Zusammensetzungen damit und Anwendungen<br />
davon<br />
Regulatory t cell epitopes, compositions<br />
and uses thereof<br />
Épitopes de lymphocytes t régulateurs,<br />
compositions et utilisations de ceux-ci<br />
(71) Epivax, Inc., 146 Clifford Street, Providence,<br />
RI 02903, US<br />
(72) De Groot, Anne, Providence, RI Rhode Island<br />
02906, US<br />
Martin, William, Cumberland, RI Rhode<br />
Island 02864, US<br />
Rivera, Dan, Providence, RI Rhode Island<br />
02903, US<br />
(74) Murphy, Colm Damien, Ipulse 26 Mallinson<br />
Road, London SW11 1BP, GB<br />
(62) 08713321.1 / 2 125 883<br />
(51) C07K 14/47 (11) 2 423 222 A1<br />
C07K 14/75 C07K 14/76<br />
C07K 14/78 C07K 14/79<br />
A61K 38/04<br />
(25) En (26) En<br />
(21) 11177634.0 (22) 29.01.2008<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MT NL<br />
NO PL PT RO SE SI SK TR<br />
(30) 30.01.2007 US 898347 P<br />
(54) Regulatorische T-Zellen-Epitopen sowie<br />
Zusammensetzungen damit und Anwendungen<br />
davon<br />
Regulatory t cell epitopes, compositions<br />
and uses thereof<br />
Épitopes de lymphocytes t régulateurs,<br />
compositions et utilisations de ceux-ci<br />
(71) Epivax, Inc., 146 Clifford Street, Providence,<br />
RI 02903, US<br />
(72) De Groot, Anne, Providence, RI Rhode Island<br />
02906, US<br />
Martin, William, Cumberland, RI Rhode<br />
Island 02864, US<br />
Rivera, Dan, Providence, RI Rhode Island<br />
02903, US<br />
(74) Murphy, Colm Damien, Ipulse 26 Mallinson<br />
Road, London SW11 1BP, GB<br />
257<br />
Anmeldungen<br />
Applications<br />
Demandes (<strong>09</strong>/<strong>2012</strong>) 29.02.<strong>2012</strong><br />
(62) 08713321.1 / 2 125 883<br />
C07K 14/475 → (51) C07K 19/00<br />
(51) C07K 14/575 (11) 2 423 223 A1<br />
C07K 17/08 A61K 38/22<br />
A61K 47/48 A61P 3/10<br />
A61P 3/04<br />
(25) Zh (26) En<br />
(21) 10766649.7 (22) 23.04.2010<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HR HU IE IS IT LI LT LU LV MC MK MT<br />
NL NO PL PT RO SE SI SK SM TR<br />
(86) CN 2010/072<strong>09</strong>4 23.04.2010<br />
(87) WO 2010/121559 2010/43 28.10.2010<br />
(30) 23.04.20<strong>09</strong> CN 20<strong>09</strong>10135363<br />
(54) NEUE EXENDINVARIANTE UND KON-<br />
JUGAT DARAUS<br />
NOVEL EXENDIN VARIANT AND<br />
CONJUGATE THEREOF<br />
NOUVEAU VARIANT D'EXENDINE ET SON<br />
CONJUGUÉ<br />
(71) Pegbio Co., Ltd., Suite 417 Building A3<br />
Biobay 218 Xinghu Street Industrial Park,<br />
Suzhou, Jiangsu 215123, CN<br />
(72) XU, Michael M., Suzhou Jiangsu 215123, CN<br />
WANG, Yongxiang, Shanghai 200240, CN<br />
ZHANG, Yinghui, Suzhou Jiangsu 215123,<br />
CN<br />
LUO, Xiaosu, Suzhou Jiangsu 215123, CN<br />
GONG, Nian, Shanghai 200240, CN<br />
ZHANG, Lijie, Suzhou Jiangsu 215123, CN<br />
ZHOU, Xiangjun, Suzhou Jiangsu 215123,<br />
CN<br />
(74) Gerbino, Angelo, et al, Jacobacci & Partners<br />
S.p.A. Corso Emilia 8, 10152 Torino, IT<br />
C07K 14/575 → (51) A61K 38/00<br />
C07K 14/705 → (51) C07C 43/225<br />
C07K 14/705 → (51) G01N 33/53<br />
(51) C07K 14/745 (11) 2 423 224 A1<br />
C12N 9/64 A61K 38/36<br />
C12N 15/57 A61P 7/04<br />
(25) En (26) En<br />
(21) 11182949.5 (22) 15.11.2006<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC NL PL PT<br />
RO SE SI SK TR<br />
AL BA HR MK RS<br />
(30) 15.11.2005 US 736680 P<br />
(54) Zusammensetzungen und Verfahren zur<br />
Hämostasenmodulierung<br />
Compositions and methods for modulating<br />
hemostasis<br />
Compositions et procédés de modulation<br />
de l'hémostase<br />
(71) The Children's Hospital of Philadelphia, 34th<br />
Street & Civic Center Boulevard, Philadelphia,<br />
PA 19104, US<br />
(72) Camire, Rodney M., Sicklerville, NJ 08081,<br />
US<br />
(74) Cripps, Joanna Elizabeth, et al, Mewburn<br />
Ellis LLP 33 Gutter Lane, London EC2V 8AS,<br />
GB<br />
(62) 06846312.4 / 1 948 690<br />
C07K 14/75 → (51) C07K 14/47<br />
C07K 14/76 → (51) C07K 14/47<br />
C07K 14/78 → (51) C07K 14/47<br />
C07K 14/79 → (51) C07K 14/47<br />
C07K 14/81 → (51) C07K 19/00